Font Size: a A A
Keyword [diffuse large B cell]
Result: 181 - 200 | Page: 10 of 10
181. Clinical Study Of Young Patients With High Risk Diffuse Large B-Cell Lymphoma(DLBCL)
182. Clinical And Pathological Characteristics Of De Novo DLBCLs With Decreased CD20 Cell Surface Expression
183. Structure Aberration Of MYC Gene And Regulation Of MYC Protein By BCR Signaling In Diffuse Large B-cell Lymphoma
184. Loss Of IRF8 Inhibits The Growth Of Diffuse Large B-cell Lymphoma
185. Efficacy Analysis On Rituximab Combined With Chemotherapy In The Treatment Of Diffuse Large B-cell Lymphoma And Bcl-2 Protein Overexpression
186. Inhibition Of Indoleamine 2, 3-Dioxygenase In CD20+ Diffuse Large B Cell Lymphoma Cell Correlates With Rituximab-mediated Antibody-dependent Cell-mediated Cytotoxicity
187. The Relationship Between CD10, Bcl-6, VEGF With The Prognosis In The Primary Gastrointestinal Diffuse Large B-cell Lymphoma
188. Prognostic Significance Of Immunohistochemical Markers In Patients With Diffuse Large B Cell Lymphoma: A Clinical Study On Prognostic Impact Of Rituximab On Immunohistochemical Markers
189. Expression And Clinical Significance Of MiR-155、miR-15a、miR-16-1 In Patients With Diffuse Large B-cell Lymphoma
190. Study Of 18F-FDG PET/CT In The Diagnosis Of Diffuse Large B Cell Lymphoma Chemotherapy Interim And Curative Effect Evaluation
191. Comparative Study Of R-GEMOX And RICE Regimens As Second-line Treatments For Refractory Or Relapsed DLBCL
192. Primary Diffuse Large B-cell Lymphoma Of Testis Involving The Skin:one Case Report And Literature Review
193. The Separation Of Specific Serum Protein Biomarker In Patients With Relapse/refractory Diffuse Large B Cell Lymphoma And The Study Of Its Clinical Value
194. Doxorubicin And Iron Oxide Nanoparticles Loaded Microbubbles:Dual-mode Imaging And Its Cytotoxic Effect On Lymphoma Cells In Vitro
195. The Analysis Of Prognosis And Clinical Features In 81 Patients With Diffuse Large B-cell Lymphoma
196. The Clinical Pathological Research Of Diffuse Large B-cell Lymphoma In Different Age Paragraph
197. Clinical Analysis Of 18 Cases Of Primary Diffuse Large B Cell Lymphoma Originated From Nasal Cavity And Paranasal Sinus And Nasopharynx
198. Expression And Clinical Significance Of CMYC,BCL2,BCL6 Protein In Diffuse Large B Cell Lymphoma
199. An Exploratory Research On Detection Of Diffuse Large B-cell Lymphoma Patients With Volatile Organic Compounds In The Breath
200. Study Of Rituximab Combined Chemotherapy On Breg And IL-10 Changes In Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
  <<First  <Prev  Next>  Last>>  Jump to